Chiasma seeks US FDA marketing approval for octreotide to treat acromegaly
Chiasma files for $86m Nasdaq IPO
Facing Your Body Image Demons - Read the article here!
Chiasma Announces New Data for Investigational Octreotide Capsules. Read all about it by clicking here...
Ipsen Announces FDA Approval of a New Delivery Device for Somatuline Depot (Lanreotide) injection. Read all about it by clicking here...
| Jill Sisco, 62990 E 282 Rd, Grove OK 74344
Phone 918-786-8209 Fax 918-787-5556